Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
NCT ID:
NCT07234812
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 and 35 years
* Generally healthy, with mild to moderate sleep disturbance as categorized by the Pittsburgh Sleep Quality Index (PSQI)
* Body Mass Index (BMI) \< 35 kg/m²
* No physical or organic limitations or diseases that would prevent participation in physical activity
* Non-smoker and non-alcoholic
* Caffeine consumption ≤ 2 cups per day (including coffee and energy drinks)
* Have not participated in more than 60 minutes/week of usual moderate-to-vigorous physical activity in the past 6 months, categorized as "moderate" on the International Physical Activity Questionnaire-Short Form (IPAQ-SF)
* No clinically diagnosed sleep apnea or other medical/psychiatric disorders responsible for sleep complaints
* Regular sleep schedule (no night shifts or transmeridian travel) in the 30 days prior to study enrollment
* Able to speak and write English
Exclusion Criteria:
* Current use of medications or psychotherapeutic drugs for insomnia or other psychiatric disorders
* Use of melatonin or other sleep aids in the past month
* Currently performing any aerobic or mind-body exercise classes (e.g., yoga, Pilates)
* Habitual daytime napping
* History of epilepsy or other convulsive disorders
* Pregnant individuals
* Habitual or recent use (within the past 30 days) of illegal drugs, psychotropic drugs, hypnotics, stimulants, or analgesics
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT07234812
Study Brief:
Protocol Section:
NCT07234812